DefinitionAcute lymphocytic leukemia (ALL) incidence refers to the number of persons newly diagnosed with ALL within a specified time period and age group. Measures include 1) the number of newly diagnosed ALL cases; and 2) age-adjusted ALL incidence rates (adjusted by the direct method to the 2000 US standard population). Measures are calculated for children < 15 years of age and < 20 years of age. All rates are expressed per 1,000,000 persons.
NumeratorThe number of ALL cases newly diagnosed in New Mexico residents within a specified time period and age group. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recodes for acute lymphocytic leukemia: 35011. http://seer.cancer.gov/siterecode/
DenominatorThe estimated population of New Mexico residents within a specified time period and age group.
Why Is This Important?Leukemia is a cancer of the blood-forming cells that affects both adults and children. Leukemia is the most common form of cancer diagnosed in children and adolescents, and often arises very rapidly over a short period (acute form). In adults, leukemia is more likely to take many years to develop (chronic form). The causes of leukemia are not well understood but appear to involve a combination of hereditary and environmental factors.
Leukemia accounts for around 1/3rd of childhood cancers. Acute lymphocytic leukemia accounts for about 75% of childhood leukemia. The five-year survival rate is 68.2%.
New Mexico averaged approximately 21 new cases of acute lymphocytic leukemia every year between 2010-2015 for children under the age of 20. Rates have remained relatively stable in New Mexico in recent decades.
Other ObjectivesCDC Environmental Public Health Tracking, Nationally Consistent Data and Measures (EPHT NCDM)